Simplex Trading, LLC Myriad Genetics Inc Transaction History

Simplex Trading, LLC

$2.98 Billion
Q2 2024

A detailed history of Simplex Trading, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 1,985 shares of MYGN stock, worth $52,523. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,985

Holding current value

$52,523

% of portfolio

0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$17.98 - $25.47 $35,690 - $50,557	1,985 New	1,985 $48,000
Q4 2023 Feb 02, 2024	SELL	$13.91 - $21.32 $61,955 - $94,959	-4,454 Reduced 91.53%	412 $7,000
Q3 2023 Nov 01, 2023	SELL	$15.99 - $23.22 $647,930 - $940,897	-40,521 Reduced 89.28%	4,866 $78,000
Q2 2023 Aug 04, 2023	BUY	$17.56 - $23.76 $503,708 - $681,555	28,685 Added 171.75%	45,387 $1.05 Million
Q1 2023 Apr 27, 2023	BUY	$15.26 - $23.75 $253,514 - $394,558	16,613 Added 18666.29%	16,702 $387,000
Q4 2022 Feb 02, 2023	BUY	$14.51 - $20.99 $1,291 - $1,868	89 New	89 $1,000
Q1 2022 May 02, 2022	SELL	$22.67 - $28.01 $108,407 - $133,943	-4,782 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$24.13 - $32.63 $55,619 - $75,212	2,305 Added 93.06%	4,782 $131,000
Q3 2021 Oct 28, 2021	SELL	$29.97 - $36.66 $20,979 - $25,661	-700 Reduced 22.03%	2,477 $77,000
Q2 2021 Aug 12, 2021	BUY	$25.39 - $32.61 $68,857 - $88,438	2,712 Added 583.23%	3,177 $97,000
Q1 2021 Apr 26, 2021	SELL	$19.92 - $31.6 $54,381 - $86,268	-2,730 Reduced 85.45%	465 $14,000
Q4 2020 Feb 02, 2021	BUY	$12.16 - $19.77 $38,851 - $63,165	3,195 New	3,195 $63,000
Q1 2020 Apr 29, 2020	SELL	$9.78 - $29.53 $102,866 - $310,596	-10,518 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$20.93 - $35.1 $126,312 - $211,828	6,035 Added 134.62%	10,518 $286,000
Q3 2019 Oct 15, 2019	SELL	$22.08 - $47.08 $214,021 - $456,346	-9,693 Reduced 68.38%	4,483 $128,000
Q2 2019 Jul 26, 2019	SELL	$22.67 - $35.0 $63,203 - $97,580	-2,788 Reduced 16.43%	14,176 $393,000
Q1 2019 Apr 18, 2019	BUY	$26.93 - $34.7 $456,840 - $588,650	16,964 New	16,964 $0
Q3 2018 Oct 23, 2018	SELL	$37.57 - $50.34 $79,873 - $107,022	-2,126 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$27.75 - $40.17 $48,479 - $70,176	1,747 Added 460.95%	2,126 $79,000
Q1 2018 Apr 26, 2018	BUY	$28.83 - $41.01 $10,926 - $15,542	379 New	379 $11,000
Q4 2017 Jan 10, 2018	SELL	$28.45 - $37.14 $234,541 - $306,182	-8,244 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$24.01 - $36.2 $197,938 - $298,432	8,244	8,244 $298,000

Others Institutions Holding MYGN

# of Institutions

232

Shares Held

92.6M

Call Options Held

117K

Put Options Held

113K

Black Rock Inc. New York, NY

15.2M
Shares

$401 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.1M
Shares

$266 Million
0.0% of portfolio
Wellington Management Group LLP Boston, MA

8.26M
Shares

$219 Million
0.04% of portfolio
Camber Capital Management LP Boston, MA

5.5M
Shares

$146 Million
3.72% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

4.4M
Shares

$116 Million
0.05% of portfolio

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $2.13B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account